Sign in

CIK 0000879169

  • Large accelerated filer

INCYTE CORP

Sign in to watch
Ticker
INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943136539
Phone
+1 302-498-6700
Business address
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Former names
INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
  1. 4 Planned sale EVP & Chief Medical Officer sold 15,634 shares at $101.70 ($1,589,978)
  2. 4 Grant or award Director acquired 241 shares (grant or award)
  3. 4 Grant or award Director acquired 245 shares (grant or award)
  4. 4 Shares withheld for taxes EVP & Chief Medical Officer gave up 13,292 shares (to pay taxes)
  5. 4 Shares withheld for taxes EVP, Head of Tech. Operations gave up 254 shares (to pay taxes)
  6. 4 Grant or award Director acquired 656 shares (grant or award)
  7. 4 Planned sale Principal Accounting Officer sold 3,374 shares at an average $99.69 ($336,350)
  8. 4 Planned sale EVP, Head of Tech. Operations sold 58,331 shares at an average $97.29 ($5,675,002)
  9. 4 Planned sale EVP & Chief Scientific Officer sold 5,808 shares at an average $95.55 ($554,965)
  10. 4 Shares withheld for taxes Director gave up 2,843 shares (to pay taxes)
  11. 4 Planned sale EVP & Chief Medical Officer sold 22,664 shares at an average $102.56 ($2,324,438)
  12. 4 Shares withheld for taxes EVP, Head of Tech. Operations gave up 326 shares (to pay taxes)
  13. 4 Grant or award EVP & General Counsel acquired 9,466 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Planned sale Principal Accounting Officer sold 769 shares at an average $102.78 ($79,038)
  16. 4 Planned sale EVP & General Counsel sold 278 shares at $104.36 ($29,012)
  17. 4 Planned sale Director sold 187,500 shares at $105.46 ($19,773,750)
  18. 4 Planned sale EVP & Chief Medical Officer sold 5,233 shares at $102.20 ($534,813)
  19. 4 Planned sale EVP & General Counsel sold 598 shares at $101.36 ($60,613)
  20. 4 Planned sale EVP, Head of Incyte Intl sold 3,074 shares at $94.02 ($289,017)

Page 5 of 82 · 1,628 filings